Oxidative stress impairs endothelial nitric oxide levels in Behçets' disease

Cutaneous and Ocular Toxicology

Volumn 30, Issue 3, 2011, Pages 217-220

  Onur, Ece ^a   Kabaroglu, Ceyda ^b   Inanir, Isil ^c   Var, Ahmet ^a   Guvenc, Yesim ^a   Gunay, Ozlem ^a   Gunduz, Kamer ^c  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Beh et's disease; malondialdehyde; nitric oxide; oxidative stress

Indexed keywords

ENDOTHELIAL NITRIC OXIDE; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OXIDATIVE STRESS; TOTAL ANTIOXIDANT STATUS;

ADULT; ANTIOXIDANTS; BEHCET SYNDROME; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRATES; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 80051526141     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.554480     Document Type: Article

References (23)

1. Behçet H. Uber rezidivierende apthose, durch ein virus verursachte geschwure am mund, am auge und an den genitalien. Dermatol Wochenschr 1937; 105:1152-1157.
2. Marshall SE. Behçet's disease. Best Pract Res Clin Rheumatol 2004;18:291-311.
3. Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38:426-433.
4. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 2007;380:50-58. (Pubitemid 46498044)
5. Rhodes P, Leone AM, Francis PL, Struthers AD, Moncada S, Rhodes PM corrected to Rhodes P. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 1995;209:590-596.
6. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335:1078-1080.
7. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-119. (Pubitemid 38077161)
8. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358. (Pubitemid 9194347)
9. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138. (Pubitemid 13203451)
10. Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S et al. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease. Br J Dermatol 2005;153:526-530. (Pubitemid 41248207)
11. Orem A, Yandi YE, Vanizor B, Cimsit G, Uydu HA, Malkoç M. The evaluation of autoantibodies against oxidatively modified lowdensity lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease. Clin Biochem 2002;35:217-224. (Pubitemid 34634184)
12. Sandikci R, Türkmen S, Güvenen G, Ayabakan H, Gülcan P, Koldas M et al. Lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease. Acta Derm Venereol 2003;83:342-346. (Pubitemid 37281540)
13. Halliwell B. Phagocyte-derived reactive species: Salvation or suicide? Trends Biochem Sci 2006;31:509-515.
14. Köse K, Yazici C, Assioglu O. The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease. Clin Biochem 2001;34:125-129. (Pubitemid 32322704)
15. Harzallah O, Kerkeni A, Baati T, Mahjoub S. Oxidative stress: Correlation with Behçet's disease duration, activity and severity. Eur J Intern Med 2008;19:541-547.
16. Taysi S, Demircan B, Akdeniz N, Atasoy M, Sari RA. Oxidant/ antioxidant status in men with Behçet's disease. Clin Rheumatol 2007;26:418-422. (Pubitemid 46486976)
17. Kiraz S, Ertenli I, Calgüneri M, Oztürk MA, Haznedaroglu IC, Altun B, Erman M, Celik I. Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol 2001;19 (Suppl 24):25-29.
18. Sancak B, Onder M, Oztas MO, Bukan N, Gürer MA. Nitric oxide levels in Behçet's disease. J Eur Acad Dermatol Venereol 2003;17:7-9. (Pubitemid 36163646)
19. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M. Increased nitric oxide production in patients with Behçet's disease: Is it a new activity marker? J Am Acad Dermatol 2002;46:50-54. (Pubitemid 34073477)
20. Er H, Evereklioglu C, Cumurcu T, Türköz Y, Ozerol E, Sahin K et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol 2002;86:653-657. (Pubitemid 34627956)
21. Orem A, Vanizor B, Cimsit G, Kiran E, Deger O, Malkoç M. Decreased nitric oxide production in patients with Behçet's disease. Dermatology (Basel) 1999;198:33-36. (Pubitemid 29086332)
22. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 2001;37:517-520.
23. Ghasemi A, Syedmoradi L, Momenan AA, Zahediasl S, Azizi F. The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentration. Scand J Clin Lab Invest 2010;70:116-121.